Opinion

Video

Leveraging Neuroimaging Modalities and Guidelines in Glioblastoma

Author(s):

Nathalie Albert, MD ,Matthias Preusser, MD

Medical experts discuss the use of various neuroimaging techniques, such as MRIs, CT scans, and PET scans, emphasizing that due to limitations of MRI it is frequently combined with other modalities to obtain more comprehensive information.

Related Videos
3 experts are featured in this series.
2 experts in this video
2 experts in this video
Matthew J. Baker, PhD
Manmeet Ahluwalia, MD, MBA, FASCO
2 experts in this video
2 experts in this video
Related Content
Renal Cell Carcinoma | stock.adobe.com
December 13th 2024

Belzutifan Earns Positive CHMP Opinion for VHL Disease–Associated Tumors, Advanced ccRCC

Federico Outlines Needs, Nuances, and Necessities in Neuroblastoma Treatment
May 10th 2021

Federico Outlines Needs, Nuances, and Necessities in Neuroblastoma Treatment

Diffuse Glioma
November 25th 2024

Perioperative Vorasidenib and Ivosidenib Remain Effective, Safe in IDH1+ Diffuse Glioma

Mirdametinib in Adult and Pediatric NF1-PN | Image Credit: © Sebastian Kaulitzki - stock.adobe.com
November 25th 2024

Mirdametinib Improves HRQOL in Adult and Pediatric Patients With NF1-PN

Larotrectinib in TRK Fusion+ CNS Tumors | Image Credit: © Katsyarina - stock.adobe.com
November 24th 2024

Larotrectinib Induces Rapid, Durable Responses in Pediatric Patients With TRK Fusion+ CNS Tumors

Tovorafenib in Pediatric BRAF-Altered R/R Low-Grade Glioma | Image Credit: © Sebastian Kaulitzki - stock.adobe.com
November 23rd 2024

Tovorafenib Leads to Durable Off-Treatment Responses in Pediatric BRAF-Altered R/R Low-Grade Glioma